Clinical Trials Directory

Trials / Completed

CompletedNCT00687128

Exercise Dose-Response on Features of the Metabolic Syndrome

Dose-Response Effects of Aerobic Exercise on Insulin Sensitivity and the Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Charles Drew University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study investigates the degree of improvement in insulin resistance and features of the metabolic syndrome in non-diabetic overweight or obese subjects after training in a low-intensity, moderate-intensity or non-aerobic exercise program, as well as self-initiated exercise behavior after the assigned exercise program.

Detailed description

The proposed study is a randomized, open study comparing low-intensity and moderate-intensity aerobic exercise versus non-aerobic (stretching) exercise on direct measurements of insulin resistance and variables associated with the metabolic syndrome. This 6-month intervention will be followed by an additional 6-month follow-up period during which subjects will be encouraged to maintain their exercise regimen (along with their prescribed diet) but without scheduled supervision. Behavioral variables associated with adherence will be analyzed along with changes in the above physiological variables.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLow-intensity treadmill exerciseTreadmill walking at 30% of VO2Reserve, 3-5 times per week at 20-60 minutes per session, progressive.
BEHAVIORALModerate-intensity treadmill exerciseTreadmill walking at 60% of VO2Reserve, 3-5 times per week at 20-60 minutes per session, progressive.
BEHAVIORALNon-aerobic stretching exerciseFloor stretching exercise, 3-5 times per week at 20-60 minutes duration per session, progressive.

Timeline

Start date
2004-10-01
Primary completion
2009-09-01
Completion
2010-04-01
First posted
2008-05-30
Last updated
2012-02-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00687128. Inclusion in this directory is not an endorsement.